Previous molecular testing demonstrated that mutations in the ANK1, SPTB, SLC4A1, SPTA1, and EPB42 genes account for 60, 10, 15, 10, and 5% cases of HS, respectively, in the United States and Europe [26, 27]. The gene discussed is SLC4A1; the disease is histiocytic sarcoma.